Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Lianfang Du

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2825-6708; OpenAlex author ID A5027569851. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2016: 2 papers · 2017: 1 paper

Papers 3

  1. Role of microenvironmental periostin in pancreatic cancer progression. Last author DOI 10.18632/oncotarget.11533↗
  2. Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. Last author DOI 10.1007/s13277-016-5321-6↗
  3. Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. Last author DOI 10.18632/oncotarget.9512↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lingxi Xing · 3 shared papers, 2016–2017 · strength 0.17
  2. Feng Gao · 3 shared papers, 2016–2017 · strength 0.17
  3. Jiajie Zhang · 3 shared papers, 2016–2017 · strength 0.17
  4. Peng Qin · 3 shared papers, 2016–2017 · strength 0.17
  5. Lizhou Lin · 3 shared papers, 2016–2017 · strength 0.17
  6. Fan Li · 3 shared papers, 2016–2017 · strength 0.17
  7. Yang Liu · 1 shared paper, 2017 · strength 0.06
  8. Yang Liu · 1 shared paper, 2016 · strength 0.05
  9. Liu Yang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.